Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#4420 ×

Regulatory Updates

Sep 18, 2026•1 min read

FDA Approves ANDA078127 for Ondansetron Oral Solution

The FDA has approved application ANDA078127 for an oral ondansetron solution (4 mg/5 mL) marketed by PAI Holdings, LLC dba PAI Pharma.